MetaADEDB 2.0 @ LMMD
etoposide phosphate
(LIQODXNTTZAGID-OCBXBXKTSA-N)
Structure
SMILES
COc1cc(cc(c1OP(=O)(O)O)OC)[C@H]1[C@H]2C(=O)OC[C@@H]2[C@@H](c2c1cc1OCOc1c2)O[C@@H]1O[C@@H]2CO[C@H](O[C@H]2[C@@H]([C@H]1O)O)C
Molecular Formula:
C29H33O16P
Molecular Weight:
668.536
Log P:
1.1045
Hydrogen Bond Acceptor:
16
Hydrogen Bond Donor:
4
TPSA:
217.17
CAS Number(s):
117091-64-2
Synonym(s)
1.
etoposide phosphate
2.
BMY 40481-30
3.
BMY-40481
4.
BMY-40481-30
5.
Etophos
6.
Etopofos
7.
Etopophos
External Link(s)
MeSHC061400
PubChem Compound6918092
BindingDB50247889
ChEBI135867
CHEMBLCHEMBL1200645
DrugCentral3944
KEGGdr:D04107
ZINC3920020
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypersensitivityFAERS: 6US FAERS
2Circumstance or information capable of leading to medication errorFAERS: 5US FAERS
3Product use in unapproved indicationFAERS: 5US FAERS
4Acute kidney injuryFAERS: 4US FAERS
5Anaphylactic shockFAERS: 2US FAERS
6Adverse eventFAERS: 1US FAERS
7Blood magnesium decreasedFAERS: 1US FAERS
8Cardiac ArrestFAERS: 1US FAERS
9Device malfunctionFAERS: 1US FAERS
10Drug administration errorFAERS: 1US FAERS
11Drug ineffectiveFAERS: 1US FAERS
12Inappropriate schedule of drug administrationFAERS: 1US FAERS
13Incorrect product storageFAERS: 1US FAERS
14Incorrect storage of drugFAERS: 1US FAERS
15Malignant neoplasm progressionFAERS: 1US FAERS
16Medication ErrorFAERS: 1US FAERS
17NauseaFAERS: 1US FAERS
18OverdoseFAERS: 1US FAERS
19PneumonitisFAERS: 1US FAERS
20Ataxia7899782CTD
21Nerve Degeneration7899782CTD
22Paresis7899782CTD
23Peripheral Nervous System Diseases7899782CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.